ADBE
50
7
CVX
37
6
AMGN
31
-5
LOW
62
4
EQR
44
-3
ADT
48
3
MAS
58
-4
MMC
55
-2
ETN
65
-2
AVB
30
-4
DE
45
-3
ALL
53
-4
REGN
53
-3
SLG
39
9
NEE
68
11
EXR
19
-3
HON
59
-4
SIG
44
3
DGX
36
-3
CHD
35
3
ADBE
50
7
CVX
37
6
AMGN
31
-5
LOW
62
4
EQR
44
-3
ADT
48
3
MAS
58
-4
MMC
55
-2
ETN
65
-2
AVB
30
-4
DE
45
-3
ALL
53
-4
REGN
53
-3
SLG
39
9
NEE
68
11
EXR
19
-3
HON
59
-4
SIG
44
3
DGX
36
-3
CHD
35
3
Financhill
Back

Sagimet Biosciences, Inc. 10K Form

Sell
35

SGMT
Sagimet Biosciences, Inc.

Last Price:
$6.09
Seasonality Move:
16.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SGMT News And Ratings

See the #1 stock for the next 7 days that we like better than SGMT

SGMT Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-10.2M
Price / Cash Flow: 0
Annual Sales: $3.67
Price / Book: 1.73

Profitability

EPS (TTM): -1.78800
Net Income (TTM): $-57.7M
Gross Margin: $0
Return on Equity: -40.34%
Return on Assets: -38.6%

Sagimet Biosciences, Inc. Earnings Forecast

Key Sagimet Biosciences, Inc. Financial Ratios

  • Per Share Earnings over the last 6 years have been positive in 2 years.

Sagimet Biosciences, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SGMT
Website: sagimet.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 13.04
Quick Ratio: 12.76

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SGMT Technical Analysis vs Fundamental Analysis

Sell
35
Sagimet Biosciences, Inc. (SGMT) is a Sell

Is Sagimet Biosciences, Inc. a Buy or a Sell?